Kambo secretion contains a complex of peptides — dermorphin, deltorphin, phyllokinin, sauvagine, phyllomedusin — that act on opioid, cardiovascular, and immune system receptors. The physical effects: a sharp drop in blood pressure followed by recovery, intense sweating, gastrointestinal purging, and sometimes brief facial swelling. Subjectively, most people describe the experience as deeply unpleasant during, and unusually clarifying after.
Clinical evidence for therapeutic effects is limited compared to the classical psychedelics. Practitioners point to applications in autoimmune disorders, chronic pain, depression, and addiction recovery, but most claims rest on traditional use and observational reports rather than controlled trials.
Kambo is legal in Mexico and most jurisdictions because it is not a controlled substance. It is, however, physically demanding and requires careful screening.